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1 General Information 
Reagents and solvents for Mukaiyama-aldol/[1,5] hydride shift cascade reaction were purified prior to use by 
the following procedures: 
 TiCl4 solution (1.0 M in CH2Cl2) was purchased from Sigma-Aldrich and used as obtained. 
 CH2Cl2 (Reagent grade, Merck) was distilled from CaH2. 
 4Å molecular sieves were purchased from Alfa Aesar and activated at 250 oC for 10 hours prior to use. 
 
Analytical thin layer chromatography (TLC) was performed using Merck 60 F254 precoated silica gel plate (0.2 
mm thickness). Subsequent to elution, plates were visualized using UV radiation (254 nm) on Spectroline 
Model ENF-24061/F 254 nm. Further visualization was possible by staining with basic solution of potassium 
permanganate or acidic solution of ceric molybdate, followed by heating on a hot plate. Flash chromatography 
was performed using Merck silica gel 60 with distilled solvents. Columns were typically packed as slurry and 
equilibrated with hexane prior to use. 
Proton nuclear magnetic resonance (1H NMR) and carbon nuclear magnetic resonance (13C NMR) spectroscopy 
were performed on Bruker Advance 300, 400 and 500 NMR spectrometers. Chemical shifts of 1H NMR spectra 
are reported as d in units of parts per million (ppm) downfield from SiMe4 (d = 0.0) and relative to the signal of 
chloroform-d (d = 7.264, singlet). Multiplicities were given as: s (singlet); d (doublet); t (triplet); q (quartet); dd 
(doublet of doublets); ddd (doublet of doublets of doublets); m (multiplets) and etc. The number of protons for a 
given resonance is indicated by nH. Coupling constants are reported as J values in Hz. Carbon nuclear magnetic 
resonance spectra (13C NMR) are reported as d in units of parts per million (ppm) downfield from SiMe4 (d 0.0) 
and relative to the signal of chloroform-d (d = 77.23, triplet). Infrared spectra were recorded on a Shimadzu IR 
Prestige-21 FT-IR Spectrometer. Liquid samples were examined as film between NaCl salt plates. High-
resolution mass spectral analysis (HRMS) was performed on Q-Tof Premier mass spectrometer (Waters 
Corporation). 
 
2 General Procedure for Cationic Cascade Reaction to Construct 8-
Oxabicyclo[3,2,1]octanes 
 
An oven-dried round bottom flask (10 mL) equipped with a magnetic stir bar was charged with 4Å molecular 
sieves (300 mg), and sealed with a rubber septum. Then acetal (0.20 mmol) and silyl enol ether (0.3 mmol, 1.5 
equiv) were dissolved in dry CH2Cl2 (2 mL) and added via syringe. After cooling the solution to -78 oC, TiCl4 
(0.24 mL of a 1.0 M solution in CH2Cl2, 0.24 mmol, 1.2 equiv) was added dropwisely. The solution was 
allowed to stir at -78 oC for 10 h and then quenched with sat. NaHCO3 (5 mL), and extracted with EtOAc (3 x 
20 mL). The combined organic layers were washed with brine (30 mL), dried over Na2SO4, and concentrated in 
vacuo. The crude product was purified by flash column chromatography on silica gel using appropriate solvents 
(hexane/diethyl ether mixture) to provide the title compound. 
 
3 Experimental Data for 8-Oxabicyclo[3,2,1]octanes 
 
Triisopropyl((1,4,4-trimethyl-2-phenethyl-8-oxabicyclo[3.2.1]octan-3-yl)oxy)silane (3a for Table 1) 
The title compound prepared following the General Procedure described above. Yield: 91% as colorless oil. 1H 
NMR (400 MHz, CDCl3): d 0.93 (s, 3H), 1.04 (s, 3H), 1.07-1.10 (m, 21H), 1.38 (s, 3H), 1.51-1.64 (m, 3H), 1.81 
(ddt, J1 = 5.2 Hz, J2 = 7.6 Hz, J3 = 12.5 Hz, 1H), 2.11-2.14 (m, 1H), 2.22-2.28 (m, 1H), 2.45 (dt, J1 = 5.1 Hz, J2 
= 10.0 Hz, 1H), 2.64-2.73 (m, 2H), 3.67 (d, J = 7.9 Hz, 1H), 3.69 (s, 1H), 7.16-7.20 (m, 3H), 7.25-7.30 (m, 2H); 
13C NMR (100 MHz, CDCl3): d 12.96, 18.56, 23.88, 25.61, 26.27, 26.81, 35.29, 36.69, 37.66, 37.94, 51.23, 
80.49, 80.96, 84.47, 125.90, 128.30, 128.41, 142.50. HRMS (ESI+) exact mass calcd for C27H46O2SiNa 
[M+Na]+ requires m/z 453.3165, found m/z 453.3164.  
 
2-Ethyl-1,4,4-trimethyl-8-oxabicyclo[3.2.1]octan-3-yl)oxy)triisopropylsilane (3b for Table 1) 
The title compound prepared following the General Procedure described above. Yield: 85% as colorless oil. 1H 
NMR (400 MHz, CDCl3): d 0.93 (s, 3H), 1.00 (t, J = 7.2 Hz, 3H), 1.03 (s, 3H), 1.08-1.14 (m, 21H), 1.30 (s, 3H), 
1.32-1.37 (m, 1H), 1.43 (t, J = 6.1 Hz, 1H), 1.51 (dt, J1 = 3.8 Hz, J2 = 12.2 Hz, 1H), 1.75-1.85 (m, 2H), 2.24 (dt, 
J1 = 3.6 Hz, J2 = 11.2 Hz, 1H), 2.42 (dt, J1 = 5.2 Hz, J2 = 10.4 Hz, 1H), 3.66 (d, J = 7.8 Hz, 1H), 3.69 (s, 1H); 
13C NMR (100 MHz, CDCl3): d 12.92, 15.47, 18.50, 23.92, 25.28, 26.22, 26.70, 36.73, 37.87, 53.13, 79.31, 
80.94, 84.43. HRMS (ESI+) exact mass calcd for C21H43O2Si [M+H]+ requires m/z 355.3032, found m/z 
355.3041. 
 
Triisopropyl((1,4,4-trimethyl-2-propyl-8-oxabicyclo[3.2.1]octan-3-yl)oxy)silane (3c for Table 1) 
The title compound prepared following the General Procedure described above. Yield: 90% as colorless oil. 1H 
NMR (400 MHz, CDCl3): d 0.91 (t, J = 7.2 Hz, 3H), 0.93 (s, 3H), 1.04 (s, 3H), 1.05-1.14 (m, 21H), 1.18-1.26 
(m, 1H), 1.28 (s, 3H), 1.32-1.42 (m, 2H), 1.46-1.54 (m, 2H), 1.64-1.73 (m, 1H), 1.79 (ddt, J1 = 4.9 Hz, J2 = 7.7 
Hz, J3 = 12.2 Hz, 1H), 2.24 (dt, J1 = 3.8 Hz, J2 = 12.0 Hz, 1H), 2.41 (dt, J1 = 4.2 Hz, J2 = 8.8 Hz, 1H), 3.65 (d, J 
= 6.0 Hz, 1H), 3.66 (s, 1H); 13C NMR (100 MHz, CDCl3): d 12.93, 14.86, 18.51, 23.91, 24.52, 25.34, 26.23, 
26.79, 35.53, 36.65, 37.89, 51.62, 80.17, 80.92, 84.47. HRMS (ESI+) exact mass calcd for C22H45O2Si [M+H]+ 
requires m/z 369.3189, found m/z 369.3202. 
 
((2-Benzyl-1,4,4-trimethyl-8-oxabicyclo[3.2.1]octan-3-yl)oxy)triisopropylsilane (3d for Table 1) 
The title compound prepared following the General Procedure described above. Yield: 92% as colorless oil. 1H 
NMR (400 MHz, CDCl3): d 0.68 (qd, J1 = 7.5 Hz, J2 = 15.1 Hz, 3H), 0.89-0.93 (m, 21H), 1.25 (s, 3H), 1.38 (s, 
3H), 1.58 (dt, J1 = 3.7 Hz, J2 = 12.2 Hz, 1H), 1.79-1.85 (m, 1H), 1.89 (dd, J1 = 5.2 Hz, J2 = 10.8 Hz, 1H), 2.24 
(dt, J1 = 4.0 Hz, J2 = 12.8 Hz, 1H), 2.46 (dt, J1 = 5.2 Hz, J2 = 10.4 Hz, 1H), 2.64 (dd, J1 = 10.9 Hz, J2 = 14.0 Hz, 
1H), 3.08 (dd, J1 = 5.1 Hz, J2 = 14.1 Hz, 1H), 3.59 (s, 1H), 3.73 (d, J = 7.7 Hz, 1H), 7.15-7.19 (m, 3H), 7.24-
7.28 (m, 2H); 13C NMR (100 MHz, CDCl3): d 12.44, 18.38, 18.41, 24.25, 25.83, 26.14, 28.03, 36.77, 37.03, 
38.15, 52.90, 75.52, 81.01, 84.43, 125.81, 128.18, 129.62, 141.51. HRMS (ESI+) exact mass calcd for 
C26H45O2Si [M+H]+ requires m/z 417.3189, found m/z 417.3204.  
 
((2-(3-(Benzyloxy)propyl)-1,4,4-trimethyl-8-oxabicyclo[3.2.1]octan-3-yl)oxy)triisopropylsilane (3e for 
Table 1) 
The title compound prepared following the General Procedure described above. Yield: 84% as colorless oil. 1H 
NMR (400 MHz, CDCl3): d 0.92 (s, 3H), 1.03 (s, 3H), 1.06-1.10 (m, 21H), 1.30 (s, 3H), 1.26-1.33 (m, 1H), 
1.48-1.55 (m, 2H), 1.66-1.74 (m, 2H), 1.75-1.85 (m, 2H), 2.24 (dt, J1 = 3.6 Hz, J2 = 12.4 Hz, 1H), 2.42 (dt, J1 = 
5.1 Hz, J2 = 10.7 Hz, 1H), 3.44 (t, J = 6.6 Hz, 2H), 3.66 (s, 2H), 4.50 (s, 2H), 7.27-7.34 (m, 5H); 13C NMR (100 
MHz, CDCl3): d 12.92, 17.72, 18.53, 23.90, 25.41, 26.24, 26.79, 29.33, 31.46, 36.64, 37.88, 51.41, 70.73, 72.91, 
80.12, 80.92, 84.48, 127.51, 127.60, 128.36, 138.58. HRMS (ESI+) exact mass calcd for C29H51O3Si [M+H]+ 
requires m/z 475.3607, found m/z 475.3595.  
 
((2-(4-(Benzyloxy)butyl)-1,4,4-trimethyl-8-oxabicyclo[3.2.1]octan-3-yl)oxy)triisopropylsilane (3f for Table 
1) 
The title compound prepared following the General Procedure described above. Yield: 89% as colorless oil. 1H 
NMR (400 MHz, CDCl3): d 0.92 (s, 3H), 1.03 (s, 3H), 1.07-1.10 (m, 21H), 1.28 (s, 3H), 1.25-1.32 (m, 1H), 
1.39-1.54 (m, 4H), 1.59-1.64 (m, 2H), 1.70-1.84 (m, 2H), 2.23 (dt, J1 = 3.2 Hz, J2 = 12.8 Hz, 1H), 2.41 (dt, J1 = 
5.1 Hz, J2 = 10.7 Hz, 1H), 3.47 (t, J = 6.4 Hz, 2H), 3.66 (s, 2H), 4.49 (s, 2H), 7.27-7.36 (m, 5H); 13C NMR (100 
MHz, CDCl3): d 12.30, 12.94, 17.72, 18.53, 23.91, 25.38, 26.23, 26.82, 27.89, 30.42, 32.84, 36.64, 37.89, 51.73, 
70.12, 72.88, 80.13, 80.91, 84.48, 127.47, 127.58, 128.34, 138.67. HRMS (ESI+) exact mass calcd for 
C30H53O3Si [M+H]+ requires m/z 489.3764, found m/z 489.3752. 
 
Triisopropyl((2-(4-methoxyphenethyl)-1,4,4-trimethyl-8-oxabicyclo[3.2.1]octan-3-yl)oxy)silane (3g for 
Table 1) 
The title compound prepared following the General Procedure described above. Yield: 84% as colorless oil. 1H 
NMR (400 MHz, CDCl3): d 0.93 (s, 3H), 1.02-1.10 (m, 24H), 1.38 (s, 3H), 1.50-1.59 (m, 3H), 1.78-1.84 (m, 
1H), 2.05-2.11 (m, 1H), 2.25 (td, J1 = 3.6 Hz, J2 = 10.0 Hz, 1H), 2.45 (td, J1 = 4.8 Hz, J2 = 10.0 Hz, 1H), 2.55-
2.62 (m, 1H), 2.64-2.72 (m, 1H), 3.67 (d, J = 7.2 Hz, 1H), 3.68 (s, 1H), 3.78 (s, 3H), 6.83 (d, J = 8.5 Hz, 2H), 
7.09 (d, J = 8.5 Hz, 2H); 13C NMR (100 MHz, CDCl3): d 12.96, 18.55, 23.88, 25.62, 26.27, 26.80, 35.57, 36.68, 
36.72, 37.93, 51.09, 55.24, 80.57, 80.96, 84.47, 113.80, 129.19, 134.60, 157.83. HRMS (ESI+) exact mass calcd 
for C28H49O3Si [M+H]+ requires m/z 461.3451, found m/z 461.3455.  
 
((2-(4-Chlorophenethyl)-1,4,4-trimethyl-8-oxabicyclo[3.2.1]octan-3-yl)oxy)triisopropylsilane (3h for Table 
1) 
The title compound prepared following the General Procedure described above. Yield: 85% as colorless oil. 1H 
NMR (400 MHz, CDCl3): d 0.93 (s, 3H), 0.99 (s, 3H), 1.10-1.10 (m, 21H), 1.37 (s, 3H), 1.50-1.59 (m, 3H), 
1.77-1.86 (m, 1H), 2.04-2.14 (m, 1H), 2.21-2.28 (m, 1H), 2.41-2.48 (m, 1H), 2.58-2.74 (m, 2H), 3.66 (s, 1H), 
3.67 (d, J = 8.2 Hz, 1H), 7.10 (d, J = 8.2 Hz, 2H), 7.24 (d, J = 8.3 Hz, 2H); 13C NMR (100 MHz, CDCl3): d 
12.96, 18.54, 23.85, 25.62, 26.26, 26.79, 35.25, 36.63, 36.93, 37.92, 51.00, 80.59, 80.88, 84.47, 128.49, 129.66, 




for Table 1) 
The title compound prepared following the General Procedure described above. Yield: 66% as colorless oil. 1H 
NMR (400 MHz, CDCl3): d 0.89 (t, J = 7.4 Hz, 3H), 0.93 (s, 3H), 1.05 (s, 3H), 1.09-1.11 (m, 22H), 1.28-1.38 
(m, 3H), 1.31 (s, 3H), 1.46-1.55 (m, 2H), 1.60 (s, 2H), 1.75-1.89 (m, 2H), 1.95 (q, J = 7.2 Hz, 2H), 2.02-2.06 (m, 
2H), 2.21-2.27 (m, 1H), 2.42 (dt, J1 = 5.1 Hz, J2 = 10.6 Hz, 1H), 3.66-3.69 (m, 2H), 5.13 (t, J = 7.1 Hz, 1H); 13C 
NMR (100 MHz, CDCl3): d 12.95, 13.85, 16.03, 18.53, 22.96, 23.90, 25.43, 26.23, 26.80, 30.02, 31.97, 36.66, 
37.90, 41.57, 51.35, 80.31, 80.98, 84.48, 124.57, 135.41. HRMS (ESI+) exact mass calcd for C27H53O2Si 
[M+H]+ requires m/z 437.3815, found m/z 437.3812. 
 
Triisopropyl((1,4,4-trimethyl-2-((E)-3-methyl-6-phenylhex-3-en-1-yl)-8-oxabicyclo[3.2.1]octan-3- 
yl)oxy)silane (3j for Table 1) 
The title compound prepared following the General Procedure described above. Yield: 52% as colorless oil. 1H 
NMR (400 MHz, CDCl3): d 0.93 (s, 3H), 1.02-1.11 (m, 21H), 1.05 (s, 3H), 1.30 (s, 3H), 1.45-1.58 (m 2H), 1.54 
(s, 3H), 1.75-1.88 (m, 3H), 2.05 (t, J = 8.4 Hz, 2H), 2.21-2.31 (m, 3H), 2.38-2.45 (m, 1H), 2.63 (t, J = 7.8 Hz, 
2H), 3.67 (s, 1H), 3.68 (d, J = 7.9 Hz, 1H), 5.18 (t, J = 6.8 Hz, 1H), 7.15-7.29 (m, 3H), 7.26-7.29 (m, 2H); 13C 
NMR (100 MHz, CDCl3): d 12.97, 16.01, 18.55, 23.90, 25.45, 26.24, 26.82, 30.00, 31.97, 36.11, 36.67, 37.91, 
41.53, 51.38, 80.35, 80.98, 84.48, 123.57, 125.69, 128.21, 128.50, 136.27, 142.33. HRMS (ESI+) exact mass 
calcd for C32H55O2Si [M+H]+ requires m/z 499.3971, found m/z 499.3975. 
 
((2-(Hex-3-yn-1-yl)-1,4,4-trimethyl-8-oxabicyclo[3.2.1]octan-3-yl)oxy)triisopropylsilane (3k for Table 1) 
The title compound prepared following the General Procedure described above. Yield: 56% as colorless oil. 1H 
NMR (400 MHz, CDCl3): d 0.93 (s, 3H), 1.05 (s, 3H), 1.10-1.13 (m, 24H), 1.30 (s, 3H), 1.47-1.56 (m, 3H), 1.80 
(ddt, J1 = 5.2 Hz, J2 = 7.7 Hz, J3 = 12.6 Hz, 1H), 1.93-2.03 (m, 1H), 2.12-2.27 (m, 5H), 2.43 (ddd, J1 = 5.2 Hz, 
J2 = 9.9 Hz, J3 = 11.6 Hz, 1H), 3.63 (s, 1H), 3.66 (d, J = 7.8 Hz, 1H); 13C NMR (100 MHz, CDCl3): d 12.43, 
12.92, 14.26, 18.52, 19.94, 23.91, 25.38, 26.23, 26.87, 32.36, 36.61, 37.89, 50.63, 79.26, 79.83, 80.77, 81.86, 
84.41. HRMS (ESI+) exact mass calcd for C25H47O2Si [M+H]+ requires m/z 407.3345, found m/z 407.3347. 
 
Triisopropyl((1,4,4-trimethyl-8-oxabicyclo[3.2.1]octan-3-yl)oxy)silane (3l for Table 1) 
The title compound prepared following the General Procedure described above. Yield: 74% as colorless oil. 1H 
NMR (400 MHz, CDCl3): d 0.93 (s, 3H), 1.02 (s, 3H), 1.09-1.12 (m, 21H), 1.29 (s, 3H), 1.47 (ddt, J1 = 1.8 Hz, 
J2 = 4.4 Hz, J3 = 12.8 Hz, 1H), 1.60 (dd, J1 = 1.2 Hz, J2 = 14.3 Hz, 1H), 1.82 (ddt, J1 = 4.2 Hz, J2 = 7.9 Hz, J3 = 
12.1 Hz, 1H), 1.98 (ddd, J1 = 1.5 Hz, J2 = 4.5 Hz, J3 = 14.3 Hz, 1H), 2.22 (ddd, J1 = 4.7 Hz, J2 = 9.9 Hz, J3 = 
12.1 Hz, 1H), 2.37 (ddd, J1 = 4.5 Hz, J2 = 10.1 Hz, J3 = 12.1 Hz, 1H), 3.68 (d, J = 8.1 Hz, 1H), 3.73 (td, J1 = 1.3 
Hz, J2 = 4.4 Hz, 1H); 13C NMR (100 MHz, CDCl3): d 12.79, 18.36, 22.71, 26.26, 26.88, 26.92, 34.56, 38.16, 
42.27, 74.05, 78.59, 83.74. HRMS (ESI+) exact mass calcd for C19H39O2Si [M+H]+ requires m/z 327.2719, 
found m/z 327.2722. 
 
((2,2-Dimethyl-8-oxabicyclo[3.2.1]octan-3-yl)oxy)triisopropylsilane (3m for Table 1) 
The title compound prepared following the General Procedure described above. Yield: 46% as colorless oil. 1H 
NMR (400 MHz, CDCl3): d 0.96 (s, 3H), 1.05 (s, 3H), 1.05-1.09 (m, 21H), 1.55 (d, J = 14.5 Hz, 1H), 1.72 (ddt, 
J1 = 4.0 Hz, J2 = 7.3 Hz, J3 = 11.2 Hz, 1H), 1.81 (ddt, J1 = 4.0 Hz, J2 = 7.3 Hz, J3 = 11.2 Hz, 1H), 2.11-2.22 (m, 
2H), 2.34-2.40 (m, 1H), 3.69 (s, 1H), 3.69 (d, J = 11.9 Hz, 1H), 4.30-4.33 (m, 1H); 13C NMR (100 MHz, 
CDCl3): d 12.78, 18.36, 23.11, 24.85, 26.92, 28.34, 36.31, 39.02, 73.44, 73.79, 82.60. HRMS (ESI+) exact mass 
calcd for C18H37O2Si [M+H]+ requires m/z 313.2563, found m/z 313.2566. 
 
((2,2-Dimethyldecahydro-1H-3,5a-epoxyheptalen-1-yl)oxy)triisopropylsilane (3n for Table 1) 
The title compound prepared following the General Procedure described above. Yield: 54% as colorless oil. 1H 
NMR (400 MHz, CDCl3): d 0.92 (s, 3H), 1.00 (s, 3H), 1.06-1.11 (m, 21H), 1.25-1.34 (m, 3H), 1.37-1.38 (m, 
1H), 1.46 (dt, J1 = 4.0 Hz, J2 = 12.0 Hz, 1H), 1.65-1.73 (m, 2H), 1.75-1.90 (m, 6H), 2.28 (dt, J1 = 4.1 Hz, J2 = 
11.2 Hz, 1H), 2.41 (dt, J1 = 4.8 Hz, J2 = 11.2 Hz, 1H), 3.54 (s, 1H), 3.63 (d, J = 8.0 Hz, 1H); 13C NMR (100 
MHz, CDCl3): d 12.94, 18.46, 22.38, 23.48, 26.26, 26.42, 30.59, 30.78, 32.21, 37.39, 37.70, 41.08, 52.91, 82.76, 




yl)oxy)propan-1-ol (3o for Table 1) 
The title compound prepared following the General Procedure described above. Yield: 57% as colorless oil. 1H 
NMR (400 MHz, CDCl3): d 0.84 (s, 3H), 1.11-1.16 (m, 21H), 1.16 (s, 3H), 1.36-1.57 (m, 3H), 1.70-1.91 (m, 
4H), 1.97 (s, 2H), 2.05-2.15 (m, 2H), 2.25 (t, J = 12.0 Hz, 1H), 2.49 (d, J = 11.9 Hz, 1H), 2.92 (brs, 1H), 3.53-
3.60 (m, 2H), 3.68 (s, 1H), 3.72-3.78 (m, 3H), 5.37 (d, J = 3.1 Hz, 1H); 13C NMR (100 MHz, CDCl3): d 13.02, 
18.19, 18.52, 23.75, 25.51, 29.10, 30.90, 31.47, 32.23, 32.79, 44.79, 48.60, 63.07, 70.95, 82.79, 84.68, 122.52, 
140.90. HRMS (ESI+) exact mass calcd for C25H49O3Si [M+H]+ requires m/z 425.3451, found m/z 425.3452. 
 
((4,4-Diethyl-1-methyl-2-phenethyl-8-oxabicyclo[3.2.1]octan-3-yl)oxy)triisopropylsilane (3ab for Table 2) 
The title compound prepared following the General Procedure described above. Yield: 85% as colorless oil. Dr: 
90:10. 1H NMR (400 MHz, CDCl3): d 0.73 (t, J = 7.6 Hz, 3H), 0.80 (t, J = 7.6 Hz, 3H), 1.03-1.14 (m, 21H), 
1.38 (s, 3H), 1.30-1.47 (m, 2H), 1.50-1.69 (m, 5H), 1.76-1.86 (m, 1H), 2.06-2.15 (m, 1H), 2.21-2.27 (m, 1H), 
2.41-2.48 (m, 1H), 2.60-2.77 (m, 2H), 3.70 (s, 0.10H for minor isomer), 3.80 (s, 0.90H for major isomer), 3.88 
(d, J = 7.77 Hz, 1H), 7.16-7.20 (m, 3H), 7.25-7.30 (m, 2H); 13C NMR (100 MHz, CDCl3): d 6.73, 8.37, 13.09, 
18.60, 22.30, 24.20, 25.64, 25.79, 35.20, 37.94, 41.90, 51.65, 76.82, 80.87, 81.84, 125.91, 128.31, 128.42, 
142.44. HRMS (ESI+) exact mass calcd for C29H51O2Si [M+H]+ requires m/z 459.3658, found m/z 459.3673. 
 
Triisopropyl((5-methyl-4-phenethyl-8-oxaspiro[bicyclo[3.2.1]octane-2,1'-cyclopentan]-3-yl)oxy)silane (3ac 
for Table 2) 
The title compound prepared following the General Procedure described above. Yield: 87% as colorless oil. Dr: 
96:4. 1H NMR (400 MHz, CDCl3): d 1.02-1.13 (m, 21H), 1.36 (s, 3H), 1.26-1.41 (m, 1H), 1.48-1.66 (m, 8H), 
1.77-1.91 (m, 2H), 1.97-2.11 (m, 2H), 2.22-2.29 (m, 1H), 2.52 (ddd, J1 = 4.9 Hz, J2 = 10.0 Hz, J3 = 11.5 Hz, 
1H), 2.63-2.73 (m, 2H), 3.77 (s, 1H), 3.80 (d, J = 7.8 Hz, 1H), 7.16-7.20 (m, 3H), 7.25-7.30 (m, 2H); 13C NMR 
(100 MHz, CDCl3): d 12.95, 18.56, 23.90, 25.36, 25.72, 26.98, 33.03, 33.10, 36.50, 36.94, 37.15, 50.47, 50.99, 
80.40, 81.24, 81.70, 125.88, 128.31, 128.40, 142.53. HRMS (ESI+) exact mass calcd for C29H49O2Si [M+H]+ 
requires m/z 457.3502, found m/z 457.3514. 
 
Triisopropyl((5-methyl-4-phenethyl-8-oxaspiro[bicyclo[3.2.1]octane-2,1'-cyclohexan]-3-yl)oxy)silane (3ad 
for Table 2) 
The title compound prepared following the General Procedure described above. Yield: 91% as colorless oil. Dr: 
93:7. 1H NMR (400 MHz, CDCl3): d 1.03-1.15 (m, 21H), 1.23-1.34 (m, 4H), 1.39 (s, 3H), 1.41-1.64 (m, 8H), 
1.79-1.88 (m, 1H), 1.93 (d, J = 12.8 Hz, 1H), 2.03-2.13 (m, 1H), 2.24-2.30 (m, 1H), 2.42-2.49 (m, 1H), 2.68 
(dtd, J1 = 5.4 Hz, J2 = 13.2 Hz, J3 = 19.2 Hz, 2H), 3.68 (s, 1H), 4.26 (d, J = 7.8 Hz, 1H), 7.16-7.20 (m, 3H), 
7.26-7.30 (m, 2H); 13C NMR (100 MHz, CDCl3): d 13.13, 18.62, 21.46, 21.60. 25.46, 25.59, 26.44, 31.68, 33.71, 
35.50, 36.90, 37.96, 39.80, 51.63, 79.25, 81.29, 81.42, 125.89, 128.30, 128.40, 142.52. HRMS (ESI+) exact 
mass calcd for C30H51O2Si [M+H]+ requires m/z 471.3658, found m/z 471.3656. 
 
4-Benzyl-1-methyl-2-phenethyl-8-oxabicyclo[3.2.1]octan-3-yl)oxy)triisopropylsilane (3ae for Table 2) 
The title compound prepared following the General Procedure described above. Yield: 96% as colorless oil. Dr: 
59:41. 1H NMR (400 MHz, CDCl3): d 1.00-1.17 (m, 21H), 1.32 (s, 1.8H) for major isomer, 1.40 (s, 1.2H) for 
minor isomer, 1.44-1.67 (m, 3H), 1.71-1.83 (m, 1H), 1.88-1.99 (m, 0.6H), 2.05-2.24 (m, 2H), 2.32-2.38 (m, 
0.6H), 2.52-2.61 (m, 1H), 2.65-2.79 (m, 3.6H), 2.85 (dd, J1 = 10.9 Hz, J2 = 13.0 Hz, 0.4H), 3.87 (dd, J1 = 2.9 Hz, 
J2 = 7.4 Hz, 0.6H), 3.92 (s, 0.4H), 4.07 (d, J = 3.5 Hz, 0.6H), 4.11 (d, J = 7.6 Hz, 0.4H), 7.14-7.32 (m, 10H); 13C 
NMR (100 MHz, CDCl3): d 12.18, 12.89, 18.27, 18.57, 25.38, 25.58, 25.82, 30.04, 32.28, 33.43, 35.48, 36.14, 
36.31, 36.46, 37.01, 38.43, 42.04, 49.27, 50.32, 51.20, 75.64, 75.80, 76.87, 80.94, 81.43, 125.93, 125.98, 126.02, 
128.33, 128.38, 128.48, 128.94, 129.40, 140.19, 140.90, 142.25, 142.47. HRMS (ESI+) exact mass calcd for 
C31H47O2Si [M+H]+ requires m/z 479.3345, found m/z 479.3353. 
 
Triisopropyl((1,4,4-trimethyl-2-phenethyl-8-oxabicyclo[3.2.1]octan-3-yl)oxy)silane (5a for Table 4) 
The title compound prepared following the General Procedure described above. Yield: 51% as colorless oil. Dr: 
97:3. 1H NMR (400 MHz, CDCl3): d 0.96 (s, 3H), 1.05 (s, 3H), 1.07-1.17 (m, 21H), 1.27 (d, J = 12.3 Hz, 1H), 
1.29 (s, 3H), 1.49-1.51 (m, 1H), 1.80-1.87 (m, 3H), 2.28-2.35 (m, 2H), 2.68-2.73 (m, 2H), 3.64 (d, J = 8.0 Hz, 
1H), 3.69 (d, J = 2.5 Hz, 1H), 7.14-7.19 (m, 3H), 7.25-7.29 (m, 2H); 13C NMR (100 MHz, CDCl3): d 14.07, 
18.81, 18.82, 23.51, 25.90, 26.97, 27.45, 29.35, 31.48, 36.33, 39.35, 46.51, 78.89, 82.74, 83.26, 125.78, 128.29, 
128.31, 142.34. HRMS (ESI+) exact mass calcd for C27H47O2Si [M+H]+ requires m/z 431.3345, found m/z 
431.3347. 
 
((2-Ethyl-1,4,4-trimethyl-8-oxabicyclo[3.2.1]octan-3-yl)oxy)triisopropylsilane (5b for Table 4) 
The title compound prepared following the General Procedure described above. Yield: 53% as colorless oil. Dr: 
93:7. 1H NMR (400 MHz, CDCl3): d 0.96 (s, 3H), 0.99 (t, J = 7.6 Hz, 3H), 1.06 (s, 3H), 1.12-1.16 (m, 21H), 
1.17-1.26 (m, 2H), 1.30 (s, 3H), 1.40-1.55 (m, 1H), 1.63-1.66 (m, 1H), 1.76-1.87 (m, 1H), 2.21-2.45 (m, 2H), 
3.63 (d, J = 8.0 Hz, 1H), 3.70 (d, J = 3.4 Hz, 1H); 13C NMR (100 MHz, CDCl3): d 12.91, 14.01, 15.07, 18.51, 
18.78, 18.83, 20.49, 23.50, 25.94, 26.94, 27.50, 31.34, 39.29, 49.46, 78.63, 82.81, 83.23. HRMS (ESI+) exact 
mass calcd for C21H43O2Si [M+H]+ requires m/z 355.3032, found m/z 355.3038. 
 
Triisopropyl((1,4,4-trimethyl-2-propyl-8-oxabicyclo[3.2.1]octan-3-yl)oxy)silane (5c for Table 4) 
The title compound prepared following the General Procedure described above. Yield: 58% as colorless oil. Dr: 
93:7. 1H NMR (400 MHz, CDCl3): d 0.91 (t, J = 7.11 Hz, 3H), 0.95 (s, 3H), 1.06 (s, 3H), 1.13-1.26 (m, 22H), 
1.28 (s, 3H), 1.33-1.51 (m, 4H), 1.69-1.73 (m, 1H), 1.78-1.88 (m, 1H), 2.20-2.44 (m, 2H), 3.63 (d, J = 7.1 Hz, 
1H), 3.67 (d, J = 4.0 Hz, 1H); 13C NMR (100 MHz, CDCl3): d 14.05, 14.46, 18.51, 18.75, 18.83, 23.54, 23.60, 
25.84, 26.96, 27.50, 30.02, 31.37, 39.30, 47.12, 79.10, 82.78, 83.22. HRMS (ESI+) exact mass calcd for 
C22H45O2Si [M+H]+ requires m/z 369.3189, found m/z 369.3192. 
 
Triisopropyl((2-(4-methoxyphenethyl)-1,4,4-trimethyl-8-oxabicyclo[3.2.1]octan-3-yl)oxy)silane (5d for 
Table 4) 
The title compound prepared following the General Procedure described above. Yield: 56% as colorless oil. Dr: 
95:5. 1H NMR (400 MHz, CDCl3): d 0.95 (s, 3H), 1.05 (s, 3H), 1.07-1.17 (m, 21H), 1.26-1.28 (m, 1H), 1.30 (s, 
3H), 1.43-1.51 (m, 1H), 1.76-1.87 (m, 3H), 2.25-2.34 (m, 2H), 2.62-2.66 (m, 2H), 3.63 (d, J = 7.9 Hz, 1H), 3.68 
(d, J = 2.6 Hz, 1H), 3.79 (s, 3H), 6.82 (d, J = 8.6 Hz, 2H), 7.07 (d, J = 8.6 Hz, 2H); 13C NMR (100 MHz, 
CDCl3): d 14.07, 18.82, 23.51, 25.89, 26.69, 27.45, 29.51, 31.48, 35.39, 39.34, 46.43, 55.26, 78.87, 82.75, 83.26, 
113.71, 129.17, 134.46, 157.70. HRMS (ESI+) exact mass calcd for C28H49O3Si [M+H]+ requires m/z 461.3451, 
found m/z 461.3448. 
 
((2,2-Dimethyldecahydro-1H-3,5a-epoxyheptalen-1-yl)oxy)triisopropylsilane (5f for Table 1) 
The title compound prepared following the General Procedure described above. Yield: 55% for two isomers, 
26% yield for the title compound. (another isomer data see 3n) 1H NMR (400 MHz, CDCl3): d 0.94 (s, 3H), 1.07 
(s, 3H), 1.11-1.15 (m, 22H), 1.25-1.38 (m, 5H), 1.49-1.58 (m, 1H), 1.61-1.64 (m, 1H), 1.75-1.87 (m, 4H), 1.92-
1.93 (m, 1H), 2.27-2.32 (m, 1H), 2.36-2.42 (m, 1H), 3.67 (s, 1H), 3.67 (d, J = 10.8 Hz, 1H); 13C NMR (100 
MHz, CDCl3): d 13.97, 18.77, 21.98, 23.07, 26.11, 27.69, 27.88, 28.04, 28.66, 31.48, 39.21, 39.61, 47.88, 80.69, 
83.74, 85.02. HRMS (ESI+) exact mass calcd for C23H45O2Si [M+H]+ requires m/z 381.3189, found m/z 
381.3194. 
Procedure for removing TIPS group 
To a solution of corresponding ether (0.1 mmol) in 5 mL THF was added TBAF (1.0 M in THF, 0.5 mL, 
3.0 equiv) at 0 °C. The reaction mixture was stirred at room temperature for 12 h. the reaction was quenched 
with half saturated NH4Cl (5 mL) and extracted with EA (3 x 10 mL). The combined organic layers were 
washed with brine (25 mL) and dried over Na2SO4, then concentrated in vacuo and purified by chromatography 
with hexane/EA as eluent gave desired alcohols in 88-94% yields 
 
1,4,4-Trimethyl-2-phenethyl-8-oxabicyclo[3.2.1]octan-3-ol (3a’ for Scheme 1) 
The title compound prepared following the General Procedure described above. Yield: 94% as white solid, bp: 
108-110 °C. 1H NMR (400 MHz, CDCl3): d 0.96 (s, 3H), 1.10 (s, 3H), 1.34 (s, 3H), 1.48-1.51 (m, 2H), 1.55-
1.71 (m, 2H), 1.84 (ddt, J1 = 4.9 Hz, J2 = 7.6 Hz, J3 = 12.4 Hz, 1H), 2.05 (ddd, J1 = 5.8 Hz, J2 = 11.0 Hz, J3 = 
15.7 Hz, 1H), 2.17-2.32 (m, 2H), 2.62-2.77 (m, 2H), 3.59 (s, 1H), 3.73 (d, J = 7.7Hz, 1H), 7.17-7.19 (m, 3H), 
7.26-7.31 (m, 2H); 13C NMR (100 MHz, CDCl3): d 22.73, 25.11, 26.09, 26.82, 33.25, 35.99, 37.26, 37.39, 76.72, 
80.80, 83.83, 125.88, 128.34, 128.44, 142.33. HRMS (ESI+) exact mass calcd for C18H27O2 [M+H]+ requires m/z 
275.2011, found m/z 275.2003. 
X-ray crystal structure analysis of 3a’ 
 
CCDC-873237 contains the supplementary crystallographic data for this paper. These data can be obtained free 
of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
 
2-(4-Methoxyphenethyl)-1,4,4-trimethyl-8-oxabicyclo[3.2.1]octan-3-ol (5d’ for Figure 2) 
The title compound prepared following the General Procedure described above. Yield: 89% as white solid. 1H 
NMR (400 MHz, CDCl3): d 0.98 (s, 3H), 1.05 (s, 3H), 1.26 (s, 3H), 1.29 (t, J = 11.6 Hz, 1H), 1.40 (d, J = 3.6 Hz, 
1H), 1.58-1.66 (m, 1H), 1.71-1.89 (m, 3H), 2.21 (dtd, J1 = 4.1 Hz, J2 = 9.8 Hz, J3 = 21.4 Hz, 2H), 2.45 (ddd, J1 
= 6.5 Hz, J2 = 9.7 Hz, J3 = 13.6 Hz, 1H), 2.72 (ddd, J1 = 5.1 Hz, J2 = 10.5 Hz, J3 = 13.6 Hz, 1H ), 3.51 (s, 1H), 
3.71 (d, J = 7.9 Hz, 1H), 3.79 (s, 3H), 6.83 (d, J = 8.5 Hz, 2H), 7.12 (d, J = 8.5 Hz, 2H); 13C NMR (100 MHz, 
CDCl3): d 22.08, 25.54, 26.57, 26.70, 28.89, 31.21, 32.06, 38.43, 45.18, 55.28, 73.45, 82.18, 82.71, 113.82, 
129.17, 134.77, 157.76. HRMS (ESI+) exact mass calcd for C19H29O3 [M+H]+ requires m/z 305.2117, found m/z 
305.2130. 
X-ray crystal structure analysis of 5d’ 
 
CCDC-873238 contains the supplementary crystallographic data for this paper. These data can be obtained free 




The title compound prepared following the General Procedure described above. Yield: 88% as white solid, bp: 
112-114 °C. 1H NMR (400 MHz, CDCl3): d 0.95 (s, 3H), 1.09 (s, 3H), 1.33 (s, 3H), 1.46-1.50 (m, 2H), 1.55-
1.69 (m, 2H), 1.84 (ddt, J1 = 4.8 Hz, J2 = 7.7 Hz, J3 = 12.6 Hz, 1H), 2.01 (ddd, J1 = 5.8 Hz, J2 = 10.9 Hz, J3 = 
15.8 Hz, 1H), 2.24 (dtd, J1 = 4.3 Hz, J2 = 9.9 Hz, J3 = 13.2 Hz, 2H), 2.58-2.73 (m, 2H), 3.55 (s, 1H), 3.73 (d, J = 
7.7 Hz, 1H), 7.11 (d, J = 8.3 Hz, 2H), 7.25 (d, J = 8.3 Hz, 2H); 13C NMR (100 MHz, CDCl3): d 22.70, 25.11, 
26.08, 26.81, 33.23, 35.31, 37.21, 37.39, 50.49, 77.17, 80.73, 83.82, 128.53, 129.67, 131.57, 140.73. HRMS 
(ESI+) exact mass calcd for C18H26ClO2 [M+H]+ requires m/z 309.1621, found m/z 309.1611. 
X-ray crystal structure analysis of 3h’ 
 
CCDC-873239 contains the supplementary crystallographic data for this paper. These data can be obtained free 
of charge from The Cambridge Crystallographic Data Centre via www.ccdc.cam.ac.uk/data_request/cif. 
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To a solution of corresponding aldehyde (30 mmol) in THF (30 mL) was added 2-propenylmagnesium 
bromide (1.0 M in THF, 45 mL) dropwise at 0 °C. The mixture was stirred at room temperature for 30 mins, 
followed by quenching with saturated NH4Cl solution (50 mL). The ultimate reaction mixture was extracted 
with Et2O (2 × 100 mL), washed with brine (100 mL), dried over anhydrous MgSO4, concentrated in vacuo 
provided the allylic alcohols as  colorless oil.  
A solution of the allylic alcohol (30 mmol) and propanoic acid (1 mL) in triethyl orthoacetate (50 mL) 
was heated at 145 °C for 2 hours and enthanol was then distilled out. The reaction was cooled to room 
temperature and washed with saturated NaHCO3 solution (100 mL) and brine (100 mL). The organic layer was 
dried over MgSO4 and concentrated in vacuo to yield the ester as colourless oil in 85-96% yields.  
To a solution of the above prepared esters (10 mmol) in 25 mL dry dichloromethane was added DIBAL-H 
(1 M in heptane, 12 mL, 1.2 equiv) dropwise at -78 °C. The mixture was stirred at that temperature for 2.5 h, 
then quenched by adding MeOH (5 mL) and saturated aqueous solution of Rochelle’s salt (15 mL). The 
resulting mixture was stirred vigorously until two clear layers were obtained (about 2 h) at room temperature. 
The two layers were separated and the aqueous layer was extracted with Et2O (3 × 20 mL). The combined 
organic layers were washed with brine (40 mL), dried over MgSO4, filtered, and concentrated in vacuo to obtain 
crude aldehydes. Flash column chromatography with hexane/EA as the eluent afforded the desired products as 
colorless oil in 75-86% yields. 
To a solution of aldehyde (2 mmol), TsOH (0.10 equiv) and 1,3-propanediol in 15 mL toluene was added 
triethylorthoformate (6 mmol, 3.0 equiv) at 0 °C. The reaction mixture was stirred for 12 h at room temperature. 
The reaction was then quenched with triethyl amine (0.5 mL) and concentrated in vacuo. The crude product was 
purified by flash column chromatography with hexane/EA as the eluent provided the desired products as 
colorless oil in 78-93% yields. 
 
(E)-2-(3-methyl-6-phenylhex-3-en-1-yl)-1,3-dioxane (1a for Table 1)  
1H NMR (400 MHz, CDCl3): d 1.32 (d, J = 13.4 Hz, 1H), 1.54 (s, 3H), 1.64-1.69 (m, 2H), 2.03-2.13 (m, 3H), 
2.30 (q, J = 7.4 Hz, 2H), 2.63 (t, J = 7.7 Hz, 2H), 3.73 (t, J = 12.2 Hz, 2H), 4.09 (dd, J1 = 5.5 Hz, J2 = 11.2 Hz, 
2H), 4.45 (t, J = 5.2 Hz, 1H), 5.20 (t, J = 7.1 Hz, 1H), 7.15-7.19 (m, 3H), 7.25-7.28 (m, 2H); 13C NMR (100 
MHz, CDCl3): d 15.95, 25.87, 29.84, 33.60, 33.83, 36.04, 66.89, 102.05, 123.85, 125.67, 128.22, 128.49, 135.07, 
142.31. HRMS (ESI+) exact mass calcd for C17H25O2 [M+H]+ requires m/z 261.1855, found m/z 261.1852. 
 
(E)-2-(3-methylhex-3-en-1-yl)-1,3-dioxane (1b for Table 1)  
1H NMR (400 MHz, CDCl3): d 0.93 (t, J = 7.5 Hz, 3H), 1.34 (d, J = 13.4 Hz, 1H), 1.59 (s, 3H), 1.65-1.71 (m, 
2H), 1.95-2.14 (m, 5H), 3.75 (t, J = 12.2 Hz, 2H), 4.10 (dd, J1 = 4.9 Hz, J2 = 11.7 Hz, 2H), 4.49 (t, J = 5.2 Hz, 
1H), 5.14 (t, J = 7.0 Hz, 1H); 13C NMR (100 MHz, CDCl3): d 14.34, 15.78, 21.15, 25.87, 33.66, 33.78, 66.90, 
102.13, 126.66, 133.52. HRMS (ESI+) exact mass calcd for C11H21O2 [M+H]+ requires m/z 185.1542, found m/z 
185.1543. 
 
(E)-2-(3-methylhept-3-en-1-yl)-1,3-dioxane (1c for Table 1)  
1H NMR (400 MHz, CDCl3): d 0.88 (t, J = 7.3 Hz, 3H), 1.30-1.39 (m, 3H), 1.59 (s, 3H), 1.67-1.72 (m, 2H), 1.95 
(q, J = 7.2 Hz, 2H), 2.02-2.14 (m, 3H), 3.75 (t, J = 12.3 Hz, 2H), 4.10 (dd, J1 = 4.9 Hz, J2 = 11.0 Hz, 2H), 4.49 
(t, J = 5.2 Hz, 1H), 5.15 (t, J = 6.9 Hz, 1H); 13C NMR (100 MHz, CDCl3): d 13.78, 15.95, 22.95, 25.88, 29.97, 
33.69, 33.89, 66.92, 102.14, 124.86, 134.21. HRMS (ESI+) exact mass calcd for C12H23O2 [M+H]+ requires m/z 
199.1698, found m/z 199.1696. 
 
(E)-2-(3-methyl-5-phenylpent-3-en-1-yl)-1,3-dioxane (1d for Table 1)  
1H NMR (400 MHz, CDCl3): d 1.32 (d, J = 13.4 Hz, 1H), 1.71 (s, 3H), 1.73-1.75 (m, 2H), 2.01-2.11 (m, 1H), 
2.13 (t, J = 7.2 Hz, 2H), 3.35 (d, J = 7.3 Hz, 2H), 3.72 (t, J = 12.3 Hz, 2H), 4.08 (dd, J1 = 4.9 Hz, J2 = 11.2 Hz, 
2H), 4.49 (t, J = 5.2 Hz, 1H), 5.37 (t, J = 7.3 Hz, 1H), 7.16-7.17 (m, 3H), 7.25-7.28 (m, 2H); 13C NMR (100 
MHz, CDCl3): d 16.13, 25.87, 33.63, 33.88, 34.17, 66.91, 102.02, 123.29, 125.70, 128.31, 128.33, 135.53, 
141.69. HRMS (ESI+) exact mass calcd for C16H23O2 [M+H]+ requires m/z 247.1698, found m/z 247.1692. 
 
(E)-2-(7-(benzyloxy)-3-methylhept-3-en-1-yl)-1,3-dioxane (1e for Table 1)  
1H NMR (400 MHz, CDCl3): d 1.33 (d, J = 13.5 Hz, 1H), 1.60 (s, 3H), 1.65-1.71 (m, 4H), 2.03-2.10 (m, 5H), 
3.46 (t, J = 6.5 Hz, 2H), 3.74 (t, J = 12.0 Hz, 2H), 4.10 (dd, J1 = 4.8 Hz, J2 = 11.4 Hz, 2H), 4.47-4.49 (m, 3H), 
5.14 (t, J = 7.1 Hz, 1H), 7.26-7.34 (m, 5H); 13C NMR (100 MHz, CDCl3): d 15.96, 24.45, 25.87, 29.83, 33.67, 
33.84, 66.92, 69.91, 72.93, 102.10, 124.11, 127.48, 127.64, 128.35, 134.86, 138.68. HRMS (ESI+) exact mass 
calcd for C19H29O3 [M+H]+ requires m/z 305.2117, found m/z 305.2120. 
 
(E)-2-(8-(benzyloxy)-3-methyloct-3-en-1-yl)-1,3-dioxane (1f for Table 1) 
1H NMR (400 MHz, CDCl3): d 1.31 (d, J = 13.4 Hz, 1H), 1.37-1.44 (m, 2H), 1.58 (s, 3H), 1.59-1.63 (m, 2H), 
1.66-1.71 (m, 2H), 1.99 (q, J = 7.2 Hz, 2H), 2.02-2.13 (m, 1H), 2.05 (t, J = 8.0 Hz, 2H), 3.46 (t, J = 6.5 Hz, 2H), 
3.74 (t, J = 12.0 Hz, 2H), 4.09 (dd, J1 = 4.8 Hz, J2 = 11.4 Hz, 2H), 4.48 (t, J = 5.2 Hz, 1H), 4.49 (s, 2H), 5.14 (t, 
J = 7.0 Hz, 1H), 7.25-7.34 (m, 5H); 13C NMR (100 MHz, CDCl3): d 15.98, 25.88, 26.36, 27.66, 29.37, 33.67, 
33.87, 66.91, 70.41, 72.88, 102.10, 124.66, 127.47, 127.63, 128.35, 134.42, 138.71. HRMS (ESI+) exact mass 
calcd for C20H31O3 [M+H]+ requires m/z 319.2273, found m/z 319.2276. 
 
(E)-2-(6-(4-methoxyphenyl)-3-methylhex-3-en-1-yl)-1,3-dioxane (1g for Table 1)  
1H NMR (400 MHz, CDCl3): d 1.33 (d, J = 13.4 Hz, 1H), 1.54 (s, 3H), 1.64-1.70 (m, 2H), 2.01-2.13 (m, 3H), 
2.27 (q, J = 7.4 Hz, 2H), 2.57 (t, J = 7.7 Hz, 2H), 3.73 (t, J = 12.2 Hz, 2H), 3.79 (s, 3H), 4.09 (dd, J1 = 4.9 Hz, J2 
= 11.6 Hz, 2H), 4.46 (t, J = 5.2 Hz, 1H), 5.18 (t, J = 7.1 Hz, 1H), 6.81 (d, J = 8.4 Hz, 2H), 7.09 (d, J = 8.4 Hz, 
2H); 13C NMR (100 MHz, CDCl3): d 15.97, 25.87, 30.07, 33.60, 33.82, 35.10, 55.25, 66.90, 102.06, 113.64, 
123.92, 129.34, 134.43, 134.95, 157.67. HRMS (ESI+) exact mass calcd for C18H27O3 [M+H]+ requires m/z 
291.1960, found m/z 291.1955. 
 
(E)-2-(6-(4-chlorophenyl)-3-methylhex-3-en-1-yl)-1,3-dioxane (1h for Table 1)  
1H NMR (400 MHz, CDCl3): d 1.33 (d, J = 13.4 Hz, 1H), 1.52 (s, 3H), 1.63-1.69 (m, 2H), 2.04 (t, J = 8.0 Hz, 
2H), 2.06-2.13 (m, 1H), 2.27 (q, J = 7.4 Hz, 2H), 2.60 (t, J = 7.6 Hz, 2H), 3.72 (t, J = 11.9 Hz, 2H), 4.09 (dd, J1 
= 4.8 Hz, J2 = 11.3 Hz, 2H), 4.44 (t, J = 5.2 Hz, 1H), 5.15 (t, J = 7.0 Hz, 1H), 7.10 (d, J = 8.2 Hz, 2H), 7.22 (d, J 
= 8.2 Hz, 2H); 13C NMR (100 MHz, CDCl3): d 15.98, 25.86, 29.62, 33.60, 33.78, 35.31, 66.89, 102.00, 123.36, 
128.28, 129.85, 131.36, 135.45, 140.68. HRMS (ESI+) exact mass calcd for C17H24ClO2 [M+H]+ requires m/z 
295.1465, found m/z 295.1468. 
 
2-((3E,7E)-3,7-dimethylundeca-3,7-dien-1-yl)-1,3-dioxane (1i for Table 1)  
1H NMR (400 MHz, CDCl3): d 0.89 (t, J = 7.3 Hz, 3H), 1.30-1.37 (m, 3H), 1.59 (s, 6H), 1.65-1.71 (m, 2H), 
1.93-2.11 (m, 9H), 3.75 (t, J = 12.4 Hz, 2H), 4.10 (dd, J1 = 4.9 Hz, J2 = 11.0 Hz, 2H), 4.48 (t, J = 5.2 Hz, 1H), 
5.13 (t, J = 6.9 Hz, 2H); 13C NMR (100 MHz, CDCl3): d 13.83, 15.98, 16.00, 23.00, 25.88, 26.63, 30.02, 33.64, 
33.84, 33.69, 66.91, 102.13, 124.57, 124.63, 134.12, 134.90. HRMS (ESI+) exact mass calcd for C17H31O2 
[M+H]+ requires m/z 267.2324, found m/z 267.2329. 
 
2-((3E,7E)-3,7-dimethyl-10-phenyldeca-3,7-dien-1-yl)-1,3-dioxane (1j for Table 1)  
1H NMR (400 MHz, CDCl3): d 1.33 (d, J = 13.4 Hz, 1H), 1.55 (s, 3H), 1.59 (s, 3H), 1.66-1.71 (m, 2H), 1.96-
2.14 (m, 7H), 2.30 (q, J = 7.4 Hz, 2H), 2.63 (t, J = 7.8 Hz, 2H), 3.74 (t, J = 11.4 Hz, 2H), 4.10 (dd, J1 = 4.8 Hz, 
J2 = 11.4 Hz, 2H), 4.49 (t, J = 5.2 Hz, 1H), 5.12 (t, J = 6.5 Hz, 1H), 5.18 (t, J = 6.9 Hz, 1H), 7.15-7.20 (m, 3H), 
7.25-7.29 (m, 2H); 13C NMR (100 MHz, CDCl3): d 15.99, 25.88, 26.60, 29.99, 33.70, 33.84, 36.15, 39.65, 66.92, 
102.13, 123.64, 124.48, 125.65, 128.22, 128.48, 134.24, 135.73, 142.43. HRMS (ESI+) exact mass calcd for 
C22H33O2 [M+H]+ requires m/z 329.2481, found m/z 329.2485. 
 
(E)-2-(3-methyldec-3-en-7-yn-1-yl)-1,3-dioxane (1k for Table 1)  
1H NMR (400 MHz, CDCl3): d 1.11 (t, J = 7.3 Hz, 3H), 1.34 (d, J = 13.4 Hz, 1H), 1.62 (s, 3H), 1.67-1.72 (m, 
2H), 2.05-2.20 (m, 9H), 3.76 (t, J = 12.2 Hz, 2H), 4.10 (dd, J1 = 5.0 Hz, J2 = 10.8 Hz, 2H), 4.50 (t, J = 5.2 Hz, 
1H), 5.19 (t, J = 6.2 Hz, 1H); 13C NMR (100 MHz, CDCl3): d 12.43, 14.33, 16.06, 19.20, 25.87, 27.80, 33.52, 
33.81, 66.90, 79.32, 81.63, 102.04, 123.29, 135.50. HRMS (ESI+) exact mass calcd for C15H25O2 [M+H]+ 
requires m/z 237.1855, found m/z 237.1865. 
 
2-(3-Methylbut-3-en-1-yl)-1,3-dioxane (1l for Table 1)  
1H NMR (400 MHz, CDCl3): d 1.34 (d, J = 13.5 Hz, 1H), 1.71-1.76 (m, 2H), 1.73 (s, 3H), 2.02-2.14 (m, 3H), 
3.76 (dt, J1 = 2.3 Hz, J2 = 12.3 Hz, 2H), 4.11 (dd, J1 = 5.0 Hz, J2 = 10.8 Hz, 2H), 4.53 (t, J = 5.2 Hz, 1H), 4.69 (s, 
1H), 4.71 (s, 1H); 13C NMR (100 MHz, CDCl3): d 22.55, 25.85, 31.92, 33.25, 66.91, 101.96, 109.91 145.20. 
HRMS (ESI+) exact mass calcd for C9H17O2 [M+H]+ requires m/z 157.1229, found m/z 157.1223. 
 
2-(But-3-en-1-yl)-1,3-dioxane (1m for Table 1)  
1H NMR (400 MHz, CDCl3): d 1.34 (d, J = 13.4 Hz, 1H), 1.66-1.72 (m, 2H), 2.02-2.18 (m, 3H), 3.76 (dt, J1 = 
2.2 Hz, J2 = 12.3 Hz, 2H), 4.11 (dd, J1 = 5.0 Hz, J2 = 10.9 Hz, 2H), 4.53 (t, J = 5.2 Hz, 1H), 4.96 (d, J = 10.2 Hz, 
1H), 5.03 (d, J = 17.1 Hz, 1H), 5.82 (tdd, J1 = 6.6 Hz, J2 = 10.2 Hz, J3 = 16.9 Hz, 1H); 13C NMR (100 MHz, 
CDCl3): d 25.84, 28.15, 34.31, 66.90, 101.73, 114.74, 138.03. HRMS (ESI+) exact mass calcd for C8H14O2Na 




2-(2-(Cyclohept-1-en-1-yl)ethyl)-1,3-dioxane (1n for Table 1)  
1H NMR (400 MHz, CDCl3): d 1.34 (d, J = 13.4 Hz, 1H), 1.41-1.48 (m, 4H), 1.64-1.73 (m, 4H), 2.03-2.10 (m, 
7H), 3.75 (dt, J1 = 2.4 Hz, J2 = 12.4 Hz, 2H), 4.10 (dd, J1 = 4.8 Hz, J2 = 10.4 Hz, 2H), 4.50 (t, J = 5.6 Hz, 1H), 
5.55 (t, J = 10.4 Hz, 1H); 13C NMR (100 MHz, CDCl3): 25.87, 26.83, 27.34, 28.28, 32.71, 32.77, 33.75, 34.38, 
66.87, 102.13, 126.02, 143.91. HRMS (ESI+) exact mass calcd for C13H23O2 [M+H]+ requires m/z 211.1698, 
found m/z 211.1701. 
 
 2-(2-(Cyclohex-1-en-1-yl)ethyl)-1,3-dioxane (1o for Table 1)  
1H NMR (400 MHz, CDCl3): d 1.33 (d, J = 13.4 Hz, 1H), 1.51-1.71 (m, 6H), 1.89-2.14 (m, 7H), 3.75 (dt, J1 = 
2.4 Hz, J2 = 12.4 Hz, 2H), 4.10 (dd, J1 = 5.0 Hz, J2 = 10.7 Hz, 2H), 4.50 (t, J = 5.2 Hz, 1H), 5.42 (s, 1H); 13C 
NMR (100 MHz, CDCl3): d 22.52, 22.98, 25.22, 25.86, 28.34, 32.15, 33.36, 66.89, 102.20, 120.90, 136.98. 
HRMS (ESI+) exact mass calcd for C12H21O2 [M+H]+ requires m/z 197.1542, found m/z 197.1544. 
General procedure for chiral acetals synthesis 
 
To a solution of corresponding achiral acetal (1 mmol) in DCM (5 mL) was added chiral diol (1.2 mmol, 
1.2 equiv) and TsOH (0.1 mmol) at room temperature. The mixture was stirred at room temperature for 5 h, 
followed by quenching with triethyl amine (0.1 mL). The reaction mixture concentrated in vacuo and purified 
by chromatography with hexane/EA as the eluent provided the desired products as colorless oil in 85-94% 
yields.  
 
(4R,6R)-4,6-dimethyl-2-((E)-3-methyl-6-phenylhex-3-en-1-yl)-1,3-dioxane (1aa for Table 3)  
Yield: 94%. [a]D20 = 16.1° (c = 4.60 in CHCl3). 1H NMR (400 MHz, CDCl3): d 1.20 (d, J = 6.1 Hz, 3H), 1.33 (d, 
J = 7.0 Hz, 4H), 1.55 (s, 3H), 1.60-1.68 (m, 2H), 1.79-1.87 (m, 1H), 2.05 (t, J = 7.9 Hz, 2H), 2.30 (q, J = 7.4 Hz, 
2H), 2.62 (t, J = 7.8 Hz, 2H), 3.91 (dqd, J1 = 2.4 Hz, J2 = 6.2 Hz, J3 = 12.4 Hz, 1H), 4.29 (p, J = 6.8 Hz, 1H), 
4.79 (t, J = 5.2 Hz, 1H), 5.20 (t, J = 7.0 Hz, 1H), 7.15-7.19 (m, 3H), 7.25-7.28 (m 2H); 13C NMR (100 MHz, 
CDCl3): d 15.97, 17.24, 21.90, 29.88, 33.56, 34.03, 36.08, 36.86, 67.50, 67.95, 93.98, 123.75, 125.66, 128.22, 
128.45, 135.16, 142.34. HRMS (ESI+) exact mass calcd for C19H29O2 [M+H]+ requires m/z 289.2168, found m/z 
289.2176. 
 
(4R,5R)-2-((E)-3-methyl-6-phenylhex-3-en-1-yl)-4,5-diphenyl-1,3-dioxolane (1ab for Table 3)  
Yield: 85%. [a]D20 = 10.0° (c = 1.03 in CHCl3). 1H NMR (400 MHz, CDCl3): d 1.62 (s, 3H), 1.97-2.02 (m, 2H), 
2.26-2.37 (m, 4H), 2.66 (t, J = 7.8 Hz, 2H), 4.73 (d, J = 7.8 Hz, 1H), 4.76 (d, J = 7.6 Hz, 1H), 5.30 (t, J = 7.0 Hz, 
1H), 5.50 (t, J = 4.5 Hz, 1H), 7.18-7.35 (m, 15H); 13C NMR (100 MHz, CDCl3): d 16.07, 29.99, 33.14, 33.66, 
36.08, 84.94, 86.81, 124.01, 125.71, 126.35, 126.81, 128.09, 128.25, 128.47, 128.50, 128.54, 128.58, 135.03, 
136.95, 138.59, 142.32. HRMS (ESI+) exact mass calcd for C28H30O2Na [M+Na]+ requires m/z 421.2144, found 
m/z 421.2151. 
 
(4R,5R)-4,5-dimethyl-2-((E)-3-methyl-6-phenylhex-3-en-1-yl)-1,3-dioxolane (1a’ for Table 3)  
Yield: 90%. [a]D20 = 59.8° (c = 0.95 in CHCl3). 1H NMR (400 MHz, CDCl3): d 1.22 (d, J = 5.6 Hz, 3H), 1.29 (d, 
J = 5.6 Hz, 3H), 1.55 (s, 3H), 1.69-1.74 (m, 2H), 2.06-2.10 (m, 2H), 2.30 (q, J = 7.6 Hz, 2H), 2.61-2.65 (m, 2H), 
3.58-3.64 (m, 2H), 5.02 (t, J = 4.7 Hz, 1H), 5.22 (t, J = 7.0 Hz, 1H), 7.15-7.19 (m, 3H), 7.25-7.28 (m, 2H); 13C 
NMR (100 MHz, CDCl3): d 16.03, 16.98, 17.31, 29.94, 33.16, 33.69, 36.06, 78.10, 79.75, 103.03, 123.66, 
125.67, 128.21, 128.48, 135.11, 142.33. HRMS (ESI+) exact mass calcd for C18H27O2 [M+H]+ requires m/z 




(4R,5R)-4,5-dimethyl-2-((E)-3-methyl-5-phenylpent-3-en-1-yl)-1,3-dioxolane (1d’ for Table 3)  
Yield: 87%. [a]D20 = -11.9° (c = 1.54 in CHCl3). 1H NMR (400 MHz, CDCl3): d 1.22 (d, J = 5.6 Hz, 3H), 1.28 
(d, J = 5.6 Hz, 3H), 1.72 (s, 3H), 1.75-1.80 (m, 2H), 2.14-2.18 (m, 2H), 3.35 (d, J = 7.3 Hz, 2H), 3.57-3.61 (m, 
2H), 5.04 (t, J = 4.7 Hz, 1H), 5.39 (t, J = 7.3 Hz, 1H), 7.16-7.18 (m, 3H), 7.25-7.28 (m, 2H); 13C NMR (100 
MHz, CDCl3): d 16.26, 16.98, 17.30, 33.19, 33.71, 34.18, 78.12, 79.76, 103.00, 123.07, 125.70, 128.31, 128.34, 
135.59, 141.67. HRMS (ESI+) exact mass calcd for C17H25O2 [M+H]+ requires m/z 261.1855, found m/z 
261.1866. 
 
(4R,5R)-2-((E)-6-(4-chlorophenyl)-3-methylhex-3-en-1-yl)-4,5-dimethyl-1,3-dioxolane (1h’ for Table 3)  
Yield: 88%. [a]D20 = 29.0° (c = 0.99 in CHCl3). 1H NMR (400 MHz, CDCl3): d 1.22 (d, J = 5.8 Hz, 3H), 1.28 (d, 
J = 5.8 Hz, 3H), 1.53 (s, 3H), 1.68-1.73 (m, 2H), 2.06-2.10 (m, 2H), 2.27 (q, J = 7.4 Hz, 2H), 2.59 (t, J = 7.6 Hz, 
2H), 3.57-3.63 (m, 2H), 5.00 (t, J = 4.7 Hz, 1H), 5.17 (t, J = 7.1 Hz, 1H), 7.09 (d, J = 8.4 Hz, 2H), 7.22 (d, J = 
8.4 Hz, 2H); 13C NMR (100 MHz, CDCl3): d 16.06, 16.97, 17.30, 29.71, 33.13, 33.65, 35.34, 78.11, 79.75, 
102.97, 123.20, 128.26, 129.85, 131.36, 135.47, 140.69. HRMS (ESI+) exact mass calcd for C18H26ClO2 
[M+H]+ requires m/z 309.1621, found m/z 309.1630. 
 
(4R,5R)-2-((E)-6-(4-methoxyphenyl)-3-methylhex-3-en-1-yl)-4,5-dimethyl-1,3-dioxolane (1g’ for Table 3)  
Yield: 92%. [a]D20 = 8.3° (c = 1.81 in CHCl3). 1H NMR (400 MHz, CDCl3): d 1.21 (d, J = 5.5 Hz, 3H), 1.28 (d, 
J = 5.5 Hz, 3H), 1.54 (s, 3H), 1.69-1.74 (m, 2H), 2.06-2.10 (m, 2H), 2.26 (q, J = 7.4 Hz, 2H), 2.56 (t, J = 7.7 Hz, 
2H), 3.57-3.61 (m, 2H), 3.76 (s, 3H), 5.01 (t, J = 4.7 Hz, 1H), 5.20 (t, J = 6.9 Hz, 1H), 6.80 (d, J = 8.5 Hz, 2H), 
7.08 (d, J = 8.5 Hz, 2H); 13C NMR (100 MHz, CDCl3): d 16.06, 16.99, 17.32, 30.17, 33.18, 33.71, 35.13, 55.19, 
78.10, 79.74, 103.03, 113.63, 123.75, 129.34, 134.40, 134.99, 157.69. HRMS (ESI+) exact mass calcd for 
C19H29O3 [M+H]+ requires m/z 305.2117, found m/z 305.2122. 
 
(4R,5R)-2-((E)-7-(benzyloxy)-3-methylhept-3-en-1-yl)-4,5-dimethyl-1,3-dioxolane (1e’ for Table 3)  
Yield: 89%. [a]D20 = 8.4° (c = 1.14 in CHCl3). 1H NMR (400 MHz, CDCl3): d 1.22 (d, J = 5.5 Hz, 3H), 1.28 (d, 
J = 5.5 Hz, 3H), 1.60 (s, 3H), 1.60-1.75 (m, 4H), 2.05-2.11 (m, 4H), 3.45 (t, J = 6.5 Hz, 2H), 3.57-3.60 (m, 2H), 
4.48 (s, 2H), 5.03 (t, J = 4.7 Hz, 1H), 5.16 (t, J = 6.9 Hz, 1H),7.25-7.34 (m, 5H);  13C NMR (100 MHz, CDCl3): 
d 16.07, 16.99, 17.31, 24.45, 29.80, 33.24, 33.70, 69.86, 72.90, 78.10, 79.74, 103.04, 123.91, 127.47, 127.63, 
128.35, 134.90, 138.68. HRMS (ESI+) exact mass calcd for C20H31O3 [M+H]+ requires m/z 319.2273, found m/z 
319.2269. 
 
(E)-4-methyl-7-phenylhept-4-enal (4a for Table 4)  
1H NMR (400 MHz, CDCl3): d 1.55 (s, 3H), 2.27-2.32 (m, 4H), 2.49 (t, J = 7.4 Hz, 2H), 2.63 (t, J = 7.7 Hz, 2H), 
5.21 (t, J = 7.0 Hz, 1H), 7.16-7.19 (m, 3H), 7.25-7.29 (m, 2H), 9.73 (s, 1H); 13C NMR (100 MHz, CDCl3): d 
16.05, 29.88, 31.83, 35.91, 42.12, 124.69, 125.77, 128.26, 128.48, 133.79, 142.08, 202.65. HRMS (ESI+) exact 
mass calcd for C14H19O [M+H]+ requires m/z 203.1436, found m/z 203.1434. 
 
(E)-4-methylhept-4-enal (4b for Table 4) 
1H NMR (400 MHz, CDCl3): d 0.93 (t, J = 7.5 Hz, 3H), 1.61 (s, 3H), 1.99 (p, J = 7.2 Hz, 2H), 2.32 (t J = 7.5 Hz, 
2H), 2.52 (t, J = 7.5 Hz, 2H), 5.16 (t, J = 6.8 Hz, 1H), 9.76 (s, 1H); 13C NMR (100 MHz, CDCl3): d 14.21, 15.91, 
21.15, 31.78, 42.15, 127.51, 132.25, 202.77. HRMS (ESI+) exact mass calcd for C8H15O [M+H]+ requires m/z 




(E)-4-methyloct-4-enal (4c for Table 4) 
1H NMR (400 MHz, CDCl3): d 0.88 (t, J = 7.4 Hz, 3H), 1.32-1.37 (m, 2H), 1.62 (s, 3H), 1.96 (q, J = 7.2 Hz, 
2H), 2.33 (t, J = 7.5 Hz, 2H), 2.52 (t, J = 7.4 Hz, 2H), 5.17 (t, J = 7.0 Hz, 1H), 9.76 (s, 1H); 13C NMR (100 MHz, 
CDCl3): d 13.76, 16.07, 22.82, 29.96, 31.90, 42.19, 125.73, 132.93, 202.78. HRMS (ESI+) exact mass calcd for 
C9H17O [M+H]+ requires m/z 141.1279, found m/z 141.1278. 
 
(E)-7-(4-methoxyphenyl)-4-methylhept-4-enal (4d for Table 4)  
1H NMR (400 MHz, CDCl3): d 1.55 (s, 3H), 2.26-2.32 (m, 4H), 2.49 (t, J = 7.1 Hz, 2H), 2.57 (t, J = 7.7 Hz, 2H), 
3.78 (s, 3H), 5.19 (t, J = 7.0 Hz, 1H), 6.82 (d, J = 8.4 Hz, 2H), 7.08 (d, J = 8.4 Hz, 2H), 9.73 (s, 1H); 13C NMR 
(100 MHz, CDCl3): d 16.06, 30.11, 31.83, 34.98, 42.12, 55.26, 113.66, 124.77, 129.34, 133.68, 134.19, 157.75, 
202.69. HRMS (ESI+) exact mass calcd for C15H20O2Na [M+Na]+ requires m/z 255.1361, found m/z 255.1357. 
 
4-Methylpent-4-enal (4e for Table 4)  
1H NMR (400 MHz, CDCl3): d 1.75 (s, 3H), 2.35 (t, J = 7.4 Hz, 2H), 2.58 (dt, J1 = 1.3 Hz, J2 = 7.3 Hz, 2H), 
4.69 (s, 1H), 4.77 (s, 1H), 9.78 (t, J = 1.7 Hz, 1H); 13C NMR (100 MHz, CDCl3): d 22.61, 29.82, 41.76, 110.68, 
143.75, 202.23. HRMS (ESI+) exact mass calcd for C6H11O [M+H]+ requires m/z 99.0810, found m/z 99.0811. 
 
3-(Cyclohept-1-en-1-yl)propanal (4f for Table 4)  
1H NMR (400 MHz, CDCl3): d 1.41-1.50 (m, 4H), 1.70-1.76 (m, 2H), 2.04-2.11 (m, 4H), 2.32 (t, J = 7.4 Hz 2H), 
2.49 (dt, J1 = 1.9 Hz, J2 = 7.4 Hz, 2H), 5.57 (t, J = 6.4 Hz, 1H), 9.75 (t, J = 1.9 Hz, 1H); 13C NMR (100 MHz, 
CDCl3): d 26.66, 27.14, 28.20, 32.43, 32.53, 32.83, 42.17, 127.01, 142.49, 202.90. HRMS (ESI+) exact mass 
calcd for C10H17O [M+H]+ requires m/z 153.1279, found m/z 153.1277. 
 
The enantiomeric excess was determined by chiral HPLC (Chiralpak OD-H, 0.1% i-PrOH/hexanes, flow rate 
1.0 mL/min, ? = 220 nm); tr = 7.37 min (major) and 11.62 min (minor) min. 97% ee. Yield: 88%. [a]D20 = 27.9° 







The enantiomeric excess was determined by chiral HPLC (Chiralpak AD-H, 0.1% i-PrOH/hexanes, flow rate 
1.0 mL/min, ? = 254 nm); tr = 5.18 min (major) and 5.68 min (minor) min. 94% ee. Yield: 91%. [a]D20 = -16.2° 






The enantiomeric excess was determined by chiral HPLC (Chiralpak OD-H, 0.5% i-PrOH/hexanes, flow rate 
1.0 mL/min, ? = 220 nm); tr = 5.24 min (major) and 9.13 min (minor) min. 94% ee. Yield: 79%. [a]D20 = 4.6° (c 






The enantiomeric excess was determined by chiral HPLC (Chiralpak AD-H, 0.5% i-PrOH/hexanes, flow rate 
1.0 mL/min, ? = 220 nm); tr = 8.78 min (minor) and 9.53 min (major) min. 95% ee. Yield: 74%. [a]D20 = 29.6° 






The enantiomeric excess was determined by chiral HPLC (Chiralpak AD-H + OD-H, 0.1% i-PrOH/hexanes, 
flow rate 0.7 mL/min, ? = 220 nm); tr = 17.82 min (minor) and 19.13 min (major) min. 98% ee. Yield: 80%. 
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